Please provide your email address to receive an email when new articles are posted on . Keratoconus is a personal area of interest. In this commentary, I will share a few of my current thoughts on the ...
BURLINGTON, Mass.--(BUSINESS WIRE)--Epion Therapeutics (Epion) announced the commencement of its Phase 3 Apricity trials for EpiSmart™, the company’s minimally-invasive keratoconus therapy. This marks ...
Please provide your email address to receive an email when new articles are posted on . A 54-year-old man was referred in late 2014 for a consultation for corneal transplant surgery in the left eye.
The average per-person inflation-adjusted lifetime cost of keratoconus treatment in 2019 was nearly $29,000, with a cumulative economic burden of $3.8 billion, a large retrospective cohort study ...
On Monday, Glaukos Corporation (NYSE:GKOS) received the “Day 74” notification from the U.S. Food and Drug Administration (FDA) acknowledging the previously submitted New Drug Application (NDA) for ...
Some of my happiest patients are those on whom I have performed laser vision correction (LVC) who no longer need glasses or contact lenses. I may not have cured a pathologic condition, but those ...
In a recent study published in Nature Biotechnology, researchers bioengineered corneal tissue for minimally invasive vision restoration. Study: Bioengineered corneal tissue for minimally invasive ...
The positive impact of AI voice assistants played a key role in aiding recovery after my Keratoconus surgery. Now, more than ever, AI technologies are increasingly being integrated into healthcare to ...
The commonly quoted number for the prevalence of keratoconus is 1:2000, which is pretty rare, although it varies by region of the world. Using mandatory health insurance data on 4.4 million patients ...
TEANECK, NJ, UNITED STATES, September 29, 2025 /EINPresswire.com/ -- The National Keratoconus Foundation (NKCF) has named Dr. Steven Greenstein, Medical Director and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results